Results 91 to 100 of about 203,757,793 (240)

Global Rather Than Vertical‐Selective Saccadic Abnormalities in Progressive Supranuclear Palsy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To test whether vertical saccades are preferentially affected in Progressive Supranuclear Palsy (PSP). Methods PSP patients (n = 24) were compared to age‐matched controls (n = 94) and two degenerative groups (Alzheimer's disease, n = 20; Lewy body disease, n = 50).
Duy Duan Nguyen   +6 more
wiley   +1 more source

College of Pharmacy Yearbook

open access: yes, 1929
Student yearbook of the New Jersey College of Pharmacy of Rutgers UniversityThe title of the College of Pharmacy Yearbook changed several times. The RX-Ray precedes the incorporation of the New Jersey College of Pharmacy into Rutgers in 1927.

core  

Graduate Student Alumni from the Cincinnati College of Pharmacy and the University of Cincinnati College of Pharmacy, 1951-2000

open access: yes, 2001
This book is available in the UC Library CatalogThis table lists the names of Graduate Student Alumni from the Cincinnati College of Pharmacy and the University of Cincinnati College of Pharmacy.
Flannery, Michael A., 1953-   +1 more
core   +1 more source

ASSORTMENTS OF DRUGS AND TECHNOLOGICAL RECEIVES, WHICH THE FIRST DOCTORS APPLIED

open access: yesРазработка и регистрация лекарственных средств, 2019
The paper presents information on how the Sumerians, doctors of Egypt, Ancient Greece and the Roman Empire treated their patients two thousand years or more ago. An attempt is made to analyze the assortments of medicines and technological methods used by
K. S. Guzev
doaj  

Vascular Disease, Non‐Steroidal Anti‐Inflammatory Drugs and Risk of Parkinson's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives A history of vascular disease has been shown to be associated with an increased risk of Parkinson's disease, but this may be due to reverse causation. In addition, non‐steroidal anti‐inflammatory drugs are thought to reduce Parkinson's disease risk, but evidence is inconsistent and confounding by prior vascular disease is possible ...
Clare Wotton   +4 more
wiley   +1 more source

CSF Cytokine Network Organization Predicts Progression Independent of Relapse and MRI Activity in Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Progression independent of relapse activity is a major determinant of long‐term disability in multiple sclerosis, but its immunopathologic basis remains incompletely understood. We investigated whether relapse‐independent progression in radiologically stable relapsing–remitting multiple sclerosis is associated with distinct ...
Antonio Bruno   +19 more
wiley   +1 more source

REGULATION OF DRUGS PRODUCTION IN RUSSIA XVI AND XVII CENTURIES: VINEYARD, PHARMACOPOEIAS, LECHEBNIK

open access: yesРазработка и регистрация лекарственных средств, 2019
The article provides an overview of the first medical manuscript sources that regulate drugs production in Russia XVI and XVII centuries: vineyard, lechebnik, pharmacopoeias.
Y. I. Zelikson
doaj  

Prilog poznavanju povijesti ljekarništva u Karlovcu

open access: yesStudia Lexicographica
This paper presents the development of pharmacy and pharmacies in the city of Karlovac based on available literature, internet sources, and data from contemporaneous newspapers.
Domagoj Bosiljevac, Suzana Inić
doaj   +1 more source

Safety and Efficacy of GLP‐1 Receptor Agonists in Adults With Epilepsy, Obesity, and Type 2 Diabetes

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Managing obesity in patients with epilepsy is complicated by the weight‐gaining properties of essential antiseizure medications (ASMs) such as valproate and pregabalin. We evaluated the safety and efficacy of initiating glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) in this population.
Hyoshin Son   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy